Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001615774-19-001498
Filing Date
2019-01-31
Accepted
2019-01-31 16:31:14
Documents
4
Period of Report
2019-01-29

Document Format Files

Seq Description Document Type Size
1 PRE 14A s115426_pre14a.htm PRE 14A 507389
2 GRAPHIC s115426_proxy1.jpg GRAPHIC 264055
3 GRAPHIC s115426_proxy2.jpg GRAPHIC 287635
4 GRAPHIC s115426_img1.jpg GRAPHIC 322769
  Complete submission text file 0001615774-19-001498.txt   1713270
Mailing Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163
Business Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

EIN.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
Type: PRE 14A | Act: 34 | File No.: 001-37606 | Film No.: 19556245
SIC: 8731 Services-Commercial Physical & Biological Research